These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
369 related articles for article (PubMed ID: 10894546)
21. Co-inheritance of alpha- and beta-thalassaemia in mice ameliorates thalassaemic phenotype. Voon HP; Wardan H; Vadolas J Blood Cells Mol Dis; 2007; 39(2):184-8. PubMed ID: 17493845 [TBL] [Abstract][Full Text] [Related]
22. Globin gene transfer for treatment of the beta-thalassemias and sickle cell disease. Sadelain M; Rivella S; Lisowski L; Samakoglu S; Rivière I Best Pract Res Clin Haematol; 2004 Sep; 17(3):517-34. PubMed ID: 15498721 [TBL] [Abstract][Full Text] [Related]
23. Genetic treatment of severe hemoglobinopathies: the combat against transgene variegation and transgene silencing. Rivella S; Sadelain M Semin Hematol; 1998 Apr; 35(2):112-25. PubMed ID: 9565154 [TBL] [Abstract][Full Text] [Related]
24. Permanent and panerythroid correction of murine beta thalassemia by multiple lentiviral integration in hematopoietic stem cells. Imren S; Payen E; Westerman KA; Pawliuk R; Fabry ME; Eaves CJ; Cavilla B; Wadsworth LD; Beuzard Y; Bouhassira EE; Russell R; London IM; Nagel RL; Leboulch P; Humphries RK Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14380-5. PubMed ID: 12391330 [TBL] [Abstract][Full Text] [Related]
25. The degree of phenotypic correction of murine beta -thalassemia intermedia following lentiviral-mediated transfer of a human gamma-globin gene is influenced by chromosomal position effects and vector copy number. Persons DA; Hargrove PW; Allay ER; Hanawa H; Nienhuis AW Blood; 2003 Mar; 101(6):2175-83. PubMed ID: 12411297 [TBL] [Abstract][Full Text] [Related]
26. Use of the hereditary persistence of fetal hemoglobin 2 enhancer to increase the expression of oncoretrovirus vectors for human gamma-globin. Fragkos M; Anagnou NP; Tubb J; Emery DW Gene Ther; 2005 Nov; 12(21):1591-600. PubMed ID: 15944728 [TBL] [Abstract][Full Text] [Related]
27. Globin gene transfer as a potential treatment for the beta-thalassaemias and sickle cell disease. Sadelain M Vox Sang; 2004 Jul; 87 Suppl 2():235-42. PubMed ID: 15209924 [No Abstract] [Full Text] [Related]
29. Progress toward safe and effective gene therapy for beta-thalassemia and sickle cell disease. Lebensburger J; Persons DA Curr Opin Drug Discov Devel; 2008 Mar; 11(2):225-32. PubMed ID: 18283610 [TBL] [Abstract][Full Text] [Related]
30. High levels of transgene expression following transduction of long-term NOD/SCID-repopulating human cells with a modified lentiviral vector. Gao Z; Golob J; Tanavde VM; Civin CI; Hawley RG; Cheng L Stem Cells; 2001; 19(3):247-59. PubMed ID: 11359950 [TBL] [Abstract][Full Text] [Related]
31. Long-term expression of the human glucocerebrosidase gene in vivo after transplantation of bone-marrow-derived cells transformed with a lentivirus vector. Kim EY; Hong YB; Lai Z; Cho YH; Brady RO; Jung SC J Gene Med; 2005 Jul; 7(7):878-87. PubMed ID: 15712335 [TBL] [Abstract][Full Text] [Related]
32. Understanding globin regulation in beta-thalassemia: it's as simple as alpha, beta, gamma, delta. Bank A J Clin Invest; 2005 Jun; 115(6):1470-3. PubMed ID: 15931385 [TBL] [Abstract][Full Text] [Related]
33. The challenge of obtaining therapeutic levels of genetically modified hematopoietic stem cells in beta-thalassemia patients. Persons DA Ann N Y Acad Sci; 2010 Aug; 1202():69-74. PubMed ID: 20712775 [TBL] [Abstract][Full Text] [Related]
34. Extended beta-globin locus control region elements promote consistent therapeutic expression of a gamma-globin lentiviral vector in murine beta-thalassemia. Hanawa H; Hargrove PW; Kepes S; Srivastava DK; Nienhuis AW; Persons DA Blood; 2004 Oct; 104(8):2281-90. PubMed ID: 15198957 [TBL] [Abstract][Full Text] [Related]
35. Gene therapy of a mouse model of protoporphyria with a self-inactivating erythroid-specific lentiviral vector without preselection. Richard E; Mendez M; Mazurier F; Morel C; Costet P; Xia P; Fontanellas A; Geronimi F; Cario-André M; Taine L; Ged C; Malik P; de Verneuil H; Moreau-Gaudry F Mol Ther; 2001 Oct; 4(4):331-8. PubMed ID: 11592836 [TBL] [Abstract][Full Text] [Related]
37. Effects of rapamycin on accumulation of alpha-, beta- and gamma-globin mRNAs in erythroid precursor cells from beta-thalassaemia patients. Fibach E; Bianchi N; Borgatti M; Zuccato C; Finotti A; Lampronti I; Prus E; Mischiati C; Gambari R Eur J Haematol; 2006 Nov; 77(5):437-41. PubMed ID: 16939628 [TBL] [Abstract][Full Text] [Related]
38. Rapid 1-hour transduction of whole bone marrow leads to long-term repopulation of murine recipients with lentivirus-modified hematopoietic stem cells. Kurre P; Anandakumar P; Kiem HP Gene Ther; 2006 Feb; 13(4):369-73. PubMed ID: 16208421 [TBL] [Abstract][Full Text] [Related]
39. The study of sequence configuration and functional impact of the (AC)n(AT)xTy motif in human beta-globin gene promoter. Chan PK; Ma ES; Philipsen S; Tan-Un KC Am J Hematol; 2007 May; 82(5):342-8. PubMed ID: 17133428 [TBL] [Abstract][Full Text] [Related]
40. Human mesenchymal stem cells (hMSCs) expressing truncated soluble vascular endothelial growth factor receptor (tsFlk-1) following lentiviral-mediated gene transfer inhibit growth of Burkitt's lymphoma in a murine model. Kyriakou CA; Yong KL; Benjamin R; Pizzey A; Dogan A; Singh N; Davidoff AM; Nathwani AC J Gene Med; 2006 Mar; 8(3):253-64. PubMed ID: 16288493 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]